Stock To Watch ~~~~~~~~ CVM up 1.49 %
@ $0.68
CEL-SCI Corporation, a biotechnology company, engages in research and
development of drugs and vaccines for the treatment of cancer and infectious
diseases. The company's primary product Multikine is a patented
immunotherapeutic agent consisting of a mixture of naturally occurring
cytokines under phase II clinical trail for the treatment of cancer. It also
develops CEL-1000 peptide product with its Ligand Epitope Antigen
Presentation System technology which is under preclinical stage for the
protection/treatment of animals against herpes, malaria, viral encephalitis,
and cancer. The company markets its products to cancer centers, physicians,
and clinics involved in immunotherapy. CEL-SCI was founded in 1983 and is
based in Vienna, Virginia.